An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
N/A
Migraine is a neurological disease characterized by moderate or severe head...
Status
Completed
Location
Montefiore/Albert Einstein /ID# 252243
Start Date
2022-12-18
Trial ID
NCT05653986
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
PHASE3
A migraine is a moderate to severe headache typically on one side of the he...
An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants
N/A
Migraine is a neurological disease characterized by moderate or severe head...
Status
Completed
Location
Edith Wolfson Medical Center /ID# 269740
Start Date
2023-06-25
Trial ID
NCT05827887
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
PHASE3
Migraine is a common neurological disorder typically characterized by attac...
Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)
PHASE3
Migraine is a common neurological disorder typically characterized by attac...